$21.51 B
Share price
Change (1 day)
Change (1 year)

BioNTech (BNTX) - Cash on Hand

Cash on Hand as of September 2023 : $16.63 B

According to BioNTech's latest financial reports the company has $16.63 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioNTech - Cash on Hand chart (from 2018 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$15.06 B541.2%
2021-12-31$2.34 B41.74%
2020-12-31$1.65 B184.06%
2019-12-31$0.58 B23.84%
2018-12-31$0.47 B127.7%
2017-12-31$0.20 B-35.6%
2016-12-31$0.32 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.22 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA